Kelly (Dingding) Shi, PhD, MBA
About Kelly (Dingding) Shi, PhD, MBA
Kelly (Dingding) Shi, PhD, MBA, is the Senior Vice President and Senior Research Analyst in Biotechnology at Jefferies, with a strong focus on oncology within the biotech sector.
Company
Kelly (Dingding) Shi is currently working at Jefferies as Senior Vice President and Senior Research Analyst in Biotechnology. She has been part of Jefferies for several years, and her roles have progressively advanced from Senior Associate, Equity Research in Biotechnology to Vice President, Senior Research Analyst in Biotechnology before her current position.
Title
Kelly (Dingding) Shi holds the title of Senior Vice President, Senior Research Analyst in Biotechnology. She has been in this role since 2021 in the New York City Metropolitan Area. Her roles at Jefferies have steadily progressed, showcasing a deepening expertise and leadership in the field.
Education and Expertise
Kelly (Dingding) Shi has a strong educational background, with a Master of Business Administration (MBA) specializing in Finance (Investment) and Healthcare Sector Management from Duke University - The Fuqua School of Business. She also holds a Doctor of Philosophy (PhD) in Oncology and Cancer Biology from UMass Chan Medical School. Additionally, she was a Postdoctoral Research Fellow at Columbia University, focusing on Oncology and Cancer Biology at the Herbert Irving Comprehensive Cancer Center. Her education equips her with substantial expertise in both scientific research and business management, particularly in healthcare.
Background
Kelly (Dingding) Shi began her professional journey in the biotech industry as a Summer Associate Consultant in Pharma/Biotech at Trinity Partners in 2016. She then joined Jefferies in 2018 as a Senior Associate in Equity Research in Biotechnology. Over the years, she has climbed the ranks at Jefferies, serving as Vice President, Senior Research Analyst in Biotechnology from 2019 to 2021, before being promoted to her current role as Senior Vice President, Senior Research Analyst in Biotechnology.
Achievements
Kelly (Dingding) Shi has been involved in the biotech industry, particularly within oncology, since at least 2018. Her science training in cancer biology and accumulated experience in equity research analysis reflects her specialized focus and expertise in the biotech sector. Combining scientific research from institutions like Columbia University and UMass Chan Medical School with business management skills gained through her MBA, Kelly has made significant strides in her field, evidenced by her rapid career advancement at Jefferies.